151 related articles for article (PubMed ID: 15633152)
21. Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial.
Prantera C; Cottone M; Pallone F; Annese V; Franzè A; Cerutti R; Bianchi Porro G
Gastroenterology; 1999 Mar; 116(3):521-6. PubMed ID: 10029609
[TBL] [Abstract][Full Text] [Related]
22. Acute renal failure in a 53-year-old woman with Crohn's disease treated with 5-aminosalicylic acid.
Haas M; Shetye KR
Am J Kidney Dis; 2001 Jul; 38(1):205-9. PubMed ID: 11431204
[No Abstract] [Full Text] [Related]
23. Obstructing Crohn's disease of the duodenum: is surgery always mandatory?
Karaoglu AO; Yukselen V
Int J Clin Pract; 2004 Feb; 58(2):221-3. PubMed ID: 15055874
[TBL] [Abstract][Full Text] [Related]
24. [Angioedema in Crohn's disease possibly due to mesalazine].
Nguyen-Khac E; Le Baron F; Thevenot T; Tiry-Lescut C; Tiry F
Gastroenterol Clin Biol; 2002 May; 26(5):535-6. PubMed ID: 12122371
[No Abstract] [Full Text] [Related]
25. [A case of Crohn's disease that shows the improvement of the gastric disorder by the administration of mesalazine powder].
Nagamata H; Torii A; Izumi M; Anami M; Yamashita N; Inadama E; Toda G
Nihon Shokakibyo Gakkai Zasshi; 2000 Oct; 97(10):1261-6. PubMed ID: 11075590
[No Abstract] [Full Text] [Related]
26. [5-aminosalicylic acid for induction of remission or clinical response in Crohn's disease--a survey of a Cochrane review].
Bjerrum JT; Munck LK; Nielsen OH
Ugeskr Laeger; 2011 Aug; 173(35):2110-3. PubMed ID: 21884660
[TBL] [Abstract][Full Text] [Related]
27. Interstitial nephritis in children with Crohn's disease.
Benador N; Grimm P; Lemire J; Griswold W; Billman G; Reznik V
Clin Pediatr (Phila); 2000 Apr; 39(4):253-4. PubMed ID: 10791141
[No Abstract] [Full Text] [Related]
28. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
Feagan BG; Sandborn WJ
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
[TBL] [Abstract][Full Text] [Related]
29. Budesonide led to a greater remission rate and fewer severe adverse events than did mesalamine in Crohn's disease.
Rutgeerts P
Gut; 1999 Jul; 45(1):13-4. PubMed ID: 10498451
[No Abstract] [Full Text] [Related]
30. [Mesalamine in the treatment of Crohn disease?].
Nielsen OH; Thomsen OO
Ugeskr Laeger; 2005 Apr; 167(15):1656-7. PubMed ID: 15892345
[No Abstract] [Full Text] [Related]
31. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables.
Cammà C; Giunta M; Rosselli M; Cottone M
Gastroenterology; 1997 Nov; 113(5):1465-73. PubMed ID: 9352848
[TBL] [Abstract][Full Text] [Related]
32. The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form.
Prantera C; Bellinvia S
Dig Liver Dis; 2005 Feb; 37(2):135-6. PubMed ID: 15733528
[No Abstract] [Full Text] [Related]
33. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
[TBL] [Abstract][Full Text] [Related]
34. 6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
Hayee BH; Harris AW
Gastroenterology; 2005 Jan; 128(1):249; author reply 249-51. PubMed ID: 15633158
[No Abstract] [Full Text] [Related]
35. Treatment of Crohn's disease at the turn of the century.
Bickston SJ; Cominelli F
N Engl J Med; 1998 Aug; 339(6):401-2. PubMed ID: 9691110
[No Abstract] [Full Text] [Related]
36. Aminosalicylate as prophylaxis for Crohn's disease.
Qasim A; Seery J; O'Morain CA
Gut; 2001 Dec; 49(6):873. PubMed ID: 11758501
[No Abstract] [Full Text] [Related]
37. [Mesalazine is effective in Crohn disease].
Quartarolo JP
Ugeskr Laeger; 2005 Apr; 167(16):1767. PubMed ID: 15898611
[No Abstract] [Full Text] [Related]
38. Inflammatory pseudotumor of the liver as the first manifestation of Crohn's disease.
Amankonah TD; Strom CB; Vierling JM; Petrovic LM
Am J Gastroenterol; 2001 Aug; 96(8):2520-2. PubMed ID: 11513216
[No Abstract] [Full Text] [Related]
39. [Mesalazine is effective in Crohn disease 2].
Quartarolo JP; Laegemidler F; Eskerod O
Ugeskr Laeger; 2005 Mar; 167(11):1308-9; author reply 1309. PubMed ID: 15830510
[No Abstract] [Full Text] [Related]
40. [Mesalazine is effective in Crohn disease 1].
Fallingborg J; Langholz E; Christensen LA; Munkholm P; Dahlerup JF
Ugeskr Laeger; 2005 Mar; 167(11):1307-8; author reply 1309. PubMed ID: 15830509
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
